BJDX Bluejay Diagnostics, Inc.
Price Chart
Executive Summary
Bluejay Diagnostics announced a private placement raising $8.5 million upfront (up to $23.6 million with warrant exercise), priced at $2.325 per share. The offering is highly dilutive given the company's $2 million market cap, but the proceeds extend cash runway into Q1 2027, supporting FDA submission efforts.
Key Financial Metrics
Actionable Insight
The offering provides a cash lifeline for FDA submission but imposes massive dilution. Monitor for Nasdaq listing compliance and warrant exercise activity. Further dilution risk remains if warrants are exercised, adding overhang.
Key Facts
- Private placement of 3,655,917 shares plus series G and H warrants at $2.325 per unit
- Gross proceeds of $8.5 million upfront, up to $15.1 million additional from warrant exercise
- Net proceeds expected to extend cash runway into Q1 2027; if warrants fully exercised, beyond FDA approval and first year of commercialization
- Offering priced at-the-market under Nasdaq rules; dilution is substantial relative to current market cap of $2M
- H.C. Wainwright & Co. acted as exclusive placement agent
- Proceeds to fund FDA approval activities (clinical studies), R&D, and working capital
Financial Impact
Immediate $8.5M gross proceeds; potential total $23.6M if all warrants exercised. Dilution of roughly 80%+ based on pre-offering share count implied by market cap.
Risk Factors
- Extreme dilution to existing shareholders
- FDA approval uncertainty could lead to further capital needs
- Warrant overhang if exercised could pressure stock price
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3305486 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 2, 2026
3d ago
|
Press Release
| $4.34 $4.51 | ▼ −3.92% | ▼ −4.61% | $4.90 (−12.90%) |
|
Jun 2, 2026
3d ago
|
PRESS-RELEASE / 8-K
| $4.34 $4.51 | ▲ +3.92% | ▲ +4.61% | $4.90 (+12.90%) |
|
May 18, 2026
17d ago
|
Insider Cluster
| — | awaiting T+1 | — | — |
|
May 7, 2026
28d ago
|
8-K
| $1.72 $1.76 | ▲ +2.33% | ▲ +2.09% | $4.90 (+184.88%) |
|
May 7, 2026
28d ago
|
Press Release
| $1.72 $1.76 | ▲ +2.33% | ▲ +2.09% | $4.90 (+184.88%) |
|
Apr 7, 2026
8w ago
|
8-K
| $2.05 $2.05 | · 0.00% | ▼ −2.54% | $4.90 (+139.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access